Francisco López‐Muñoz

5.7k total citations
273 papers, 3.7k citations indexed

About

Francisco López‐Muñoz is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Francisco López‐Muñoz has authored 273 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Psychiatry and Mental health, 43 papers in Pharmacology and 36 papers in Experimental and Cognitive Psychology. Recurrent topics in Francisco López‐Muñoz's work include Schizophrenia research and treatment (39 papers), Treatment of Major Depression (31 papers) and Psychology Research and Bibliometrics (24 papers). Francisco López‐Muñoz is often cited by papers focused on Schizophrenia research and treatment (39 papers), Treatment of Major Depression (31 papers) and Psychology Research and Bibliometrics (24 papers). Francisco López‐Muñoz collaborates with scholars based in Spain, United States and Portugal. Francisco López‐Muñoz's co-authors include Cecilio Álamo, Gabriel Rubio, Pilar García‐García, J Boya, E Cuenca, Alejandro Romero, Winston W. Shen, Juan D. Molina, Patrick Clervoy and Eva Ramos and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Francisco López‐Muñoz

254 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco López‐Muñoz Spain 28 1.0k 636 584 509 323 273 3.7k
Cecilio Álamo Spain 27 981 1.0× 508 0.8× 343 0.6× 462 0.9× 256 0.8× 144 2.7k
Chad Bousman Australia 38 1.1k 1.0× 636 1.0× 742 1.3× 404 0.8× 708 2.2× 188 4.4k
Mark Horowitz United Kingdom 27 682 0.7× 1.0k 1.6× 358 0.6× 466 0.9× 247 0.8× 88 3.6k
Joanna M. Biernacka United States 39 1.2k 1.2× 622 1.0× 1.1k 1.9× 521 1.0× 382 1.2× 213 4.9k
Koichi Otani Japan 31 1.4k 1.4× 695 1.1× 507 0.9× 688 1.4× 290 0.9× 204 3.5k
Michael Davidson United States 39 1.4k 1.4× 1.0k 1.6× 906 1.6× 373 0.7× 361 1.1× 121 7.0k
Robert Alexander United States 21 494 0.5× 333 0.5× 692 1.2× 375 0.7× 381 1.2× 68 3.0k
Jeffrey R. Bishop United States 38 1.7k 1.7× 386 0.6× 719 1.2× 379 0.7× 878 2.7× 162 4.4k
Pao‐Yen Lin Taiwan 36 1.3k 1.2× 339 0.5× 544 0.9× 587 1.2× 549 1.7× 176 4.6k
David B Menkes New Zealand 29 695 0.7× 487 0.8× 513 0.9× 839 1.6× 238 0.7× 121 3.0k

Countries citing papers authored by Francisco López‐Muñoz

Since Specialization
Citations

This map shows the geographic impact of Francisco López‐Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco López‐Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco López‐Muñoz more than expected).

Fields of papers citing papers by Francisco López‐Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco López‐Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco López‐Muñoz. The network helps show where Francisco López‐Muñoz may publish in the future.

Co-authorship network of co-authors of Francisco López‐Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco López‐Muñoz. A scholar is included among the top collaborators of Francisco López‐Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco López‐Muñoz. Francisco López‐Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Muñoz, Francisco, et al.. (2024). De la bruja “pecadora” a la bruja “demente”. 5(2). 73–89.
2.
López‐Muñoz, Francisco, et al.. (2023). Direct and Indirect Management Models in Public Health in the Framework of Mental Health. International Journal of Environmental Research and Public Health. 20(3). 2279–2279. 1 indexed citations
3.
López‐Muñoz, Francisco, et al.. (2023). Determinants of Public Health Personnel Spending in Spain. International Journal of Environmental Research and Public Health. 20(5). 4024–4024.
4.
López‐Muñoz, Francisco, et al.. (2022). Scientific research on verbal fluency tests: A bibliometric analysis. Journal of Neurolinguistics. 63. 101082–101082. 13 indexed citations
5.
Knez, Damijan, Stanislav Gobec, Isabel Iriepa, et al.. (2022). Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment. Antioxidants. 11(9). 1735–1735. 6 indexed citations
6.
López‐Muñoz, Francisco, et al.. (2020). High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study. Psychiatry and Clinical Psychopharmacology. 30(4). 335–345. 2 indexed citations
7.
López‐Muñoz, Francisco, et al.. (2018). A History of the Pharmacological Treatment of Bipolar Disorder. International Journal of Molecular Sciences. 19(7). 2143–2143. 74 indexed citations
8.
López‐Muñoz, Francisco, et al.. (2017). Prevalencia y factores de riesgo de leucomalacia periventricular en recién nacidos prematuros. Revisión sistemática. Revista de Neurología. 65(2). 57–57. 14 indexed citations
9.
López‐Muñoz, Francisco, et al.. (2016). Los animales mitológicos como engendro de venenos y antídotos en la España Aurea: a propósito del basilisco y el unicornio en las obras literarias de Lope de Vega. 71–127. 1 indexed citations
10.
Romero, Alejandro, Eva Ramos, María Jesús Oset‐Gasque, et al.. (2016). Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Frontiers in Aging Neuroscience. 8. 281–281. 10 indexed citations
11.
López‐Muñoz, Francisco, et al.. (2014). El fenómeno de las redes sociales: evolución y perfil del usuario. Dialnet (Universidad de la Rioja). 13(1). 93–118. 2 indexed citations
12.
López‐Muñoz, Francisco, et al.. (2010). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (I): fundamentos neurobiológicos y problemas metodológicos. 9(2). 235–262. 1 indexed citations
13.
López‐Muñoz, Francisco, et al.. (2008). La introducción clínica de la iproniazida y la imipramina: medio siglo de terapéutica antidepresiva. Pain. 24(2). 56–70. 3 indexed citations
14.
López‐Muñoz, Francisco, et al.. (2007). [Differences in management of depression in Spain from psychiatric and primary care physician point of view].. PubMed. 35(2). 89–98. 3 indexed citations
15.
López‐Muñoz, Francisco, Gabriel Rubio, Cecilio Álamo, Pilar García‐García, & Antonio Pardo. (2006). Reboxetine Addition in Patients With Mirtazapine-resistant Depression. Clinical Neuropharmacology. 29(4). 192–196. 5 indexed citations
16.
López‐Muñoz, Francisco, J Boya, & Cecilio Álamo. (2006). Neuron theory, the cornerstone of neuroscience, on the centenary of the Nobel Prize award to Santiago Ramón y Cajal. Brain Research Bulletin. 70(4-6). 391–405. 80 indexed citations
17.
Bhatara, Vinod S., Francisco López‐Muñoz, & C. Fernández‐Gutiérrez. (2004). El papel de la medicina herbal ayurvédica en el descubrimiento de las propiedades neurolépticas de la reserpina: a propósito de la Rauwolfia serpentina y los orígenes de la era antipsicótica. 20(6). 274–281. 1 indexed citations
18.
López‐Muñoz, Francisco, et al.. (2004). El papel histórico de los barbitúricos en las "curas de sueño" de los trastornos psicóticos y maníacos. Psiquiatría Biológica. 11(6). 242–251. 6 indexed citations
19.
GUZMAN, A., et al.. (2004). Synthesis of Potential Anti-inflammatory Compounds, Selective Inhibitors of Cyclooxygenase-2 (COX-2). LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 48(4). 230–234. 4 indexed citations
20.
López‐Muñoz, Francisco, Cecilio Álamo, & E Cuenca. (2000). La "Década de oro" de la psicofarmacología (1950-1960): trascendencia histórica de la introducción clínica de los psicofármacos clásicos.. 4(3). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026